vimarsana.com

Latest Breaking News On - Entrada therapeutics inc - Page 4 : vimarsana.com

Reviewing Fulcrum Therapeutics (NASDAQ:FULC) & Vertex Pharmaceuticals (NASDAQ:VRTX)

Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Profitability This table compares Fulcrum Therapeutics and Vertex […]

Entrada Therapeutics to Present at Upcoming Investor Conferences

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) Entrada Therapeutics, Inc. (Nasdaq: TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics

Entrada Therapeutics, Inc (NASDAQ:TRDA) CEO Sells $15,990 00 in Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CEO Dipal Doshi sold 1,000 shares of Entrada Therapeutics stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $15.99, for a total transaction of $15,990.00. Following the completion of the transaction, the chief executive officer now directly […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.